PharmaVoice
FEBRUARY 24, 2025
Health agency job cuts and a newly-established MAHA commission leave many unanswered questions about potential reforms and impact on drug approvals.
BioPharma Dive
FEBRUARY 24, 2025
Cavazzoni stepped down from her role as head of the FDA’s main drug review office in mid-January. She will succeed Aida Habtezion.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Patent Watch
FEBRUARY 24, 2025
Breaking News: FDA Updates - What Do the Latest Changes Mean for Generic Drug Approval? Hey there, fellow healthcare professionals and industry experts! I'm excited to share with you the latest updates from the FDA that could significantly impact the generic drug approval process. As you may know, the FDA has been working tirelessly to improve the efficiency and transparency of the generic drug approval process.
Pharmaceutical Technology
FEBRUARY 24, 2025
With Novo Nordisks blockbuster drugs Wegovy and Ozempic back in stock, copycat versions are no longer allowed for now.
Speaker: Jennifer Hill
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
BioPharma Dive
FEBRUARY 24, 2025
An industry source said “most, if not all” of the people at CDRH who were recently dismissed are now being asked to return.
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
BioPharma Dive
FEBRUARY 24, 2025
Early-phase clinical trials, including phase 1 and some phase 2a studies, serve as a pivotal step for biotech companies, laying the foundation for a drug candidate’s journey to market.
Pharma Times
FEBRUARY 24, 2025
It is hoped that the approach will lead to more targeted treatments for childhood cancers
pharmaphorum
FEBRUARY 24, 2025
Mirum Pharma's Ctexli has become the first FDA-approved therapy for ultra-rare disease cerebrotendinous xanthomatosis (CTX)
BioPharma Dive
FEBRUARY 24, 2025
The partners will test Summit’s ivonescimab alongside Pfizer’s antibody-drug conjugates in hopes of finding “potentially landscape-changing combinations.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
pharmaphorum
FEBRUARY 24, 2025
At risk of defaulting on financial commitments, gene therapy firm bluebird bio has agreed to sell itself to private equity firms at a knockdown price.
Pharmaceutical Technology
FEBRUARY 24, 2025
In an anonymous post in the BMJ, the author claims that words relating to DEI could lead to grants being taken away.
pharmaphorum
FEBRUARY 24, 2025
The FDA has started a priority review of Bristol Myers Squibb's Opdivo and Yervoy as first-line therapy for MSI-H and dMMR colorectal cancer
Pharmaceutical Technology
FEBRUARY 24, 2025
MeiraGTxs investigational gene therapy AAV-AIPL1 has improved the sight of 11 children who were born blind.
Advertisement
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
pharmaphorum
FEBRUARY 24, 2025
The FDA has said there is no longer a shortage in the US market for Novo Nordisk's GLP-1 agonist semaglutide, ending sales of compounded forms.
Pharmaceutical Technology
FEBRUARY 24, 2025
Celltrion has secured marketing authorisation from the EC for Avtozma, a biosimilar to Chugai Pharmaceuticals RoActemra (tocilizumab).
PharmaTech
FEBRUARY 24, 2025
Cerebrotendinous xanthomatosis, or CTX, is a metabolic disorder caused by a gene mutation that results in a deficiency of an important enzyme in the ability of the human body to break down fats.
Pharmaceutical Commerce
FEBRUARY 24, 2025
The latest news for pharma industry insiders.
Speaker: Joe Sharpe and James Carlson
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
Pharmaceutical Technology
FEBRUARY 24, 2025
Teva Pharmaceuticals and Alvotech have announced the US launch of Selarsdi (ustekinumab-aekn) injection, a biosimilar to J&Js Stelara.
Pharmaceutical Commerce
FEBRUARY 24, 2025
In the first part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Tom Dorsett, CEO, RazorMetrics, explains the concept of polypharmacy, including how prominent it is in the United States today.
Pharmaceutical Technology
FEBRUARY 24, 2025
Mirum Pharmaceuticals Ctexli (chenodiol) has gained US Food and Drug Administration (FDA) approval for treating adults with CTX.
World Pharma News
FEBRUARY 24, 2025
New research suggests that antidepressants can accelerate cognitive decline in people with dementia. At the same time, some drugs appear to be less harmful than others, which can help doctors make better treatment decisions, according to the study published in BMC Medicine. Antidepressants are often used to relieve symptoms such as anxiety, depression, aggressiveness, and sleep disturbances in dementia sufferers.
Advertisement
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
BioPharma Dive
FEBRUARY 24, 2025
Detailed results presented at a medical congress help reinforce analyst expectations the drug, called duvakitug, will be competitive with other Crohn’s, colitis medicines in testing.
Pharmacy Times
FEBRUARY 24, 2025
The FDAs accelerated approval of lifileucel (Amtagvi; Iovance Biotherapeutics) marks a major milestone in immunotherapy for metastatic melanoma, building on decades of research in tumor-infiltrating lymphocyte therapy.
BioPharma Dive
FEBRUARY 24, 2025
Mirum gained the drug, which it will sell as Ctexli for adults with cerebrotendinous xanthomatosis, in a 2023 deal with Travere Therapeutics.
PharmaTech
FEBRUARY 24, 2025
More and more contract manufacturers have been looking not at what the state of the supply chain is right now, but what it may be in the next three to five years.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Expert insights. Personalized for you.
259 
Let's personalize your content